Skip to content
healthcare.dev

Aleve PM

NDC 0280-1200, DIPHENHYDRAMINE HYDROCHLORIDE and NAPROXEN SODIUM, tablet, film coated, from Bayer HealthCare LLC..

Product NDC
0280-1200
Status
Listed
Labeler
Bayer HealthCare LLC.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
NDA
Application
NDA205352
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0280-1200 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DIPHENHYDRAMINE HYDROCHLORIDE25 mg/1
  • NAPROXEN SODIUM220 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
0280-1200-01002801200011 BOTTLE in 1 CARTON (0280-1200-01) / 120 TABLET, FILM COATED in 1 BOTTLE
0280-1200-02002801200022 TABLET, FILM COATED in 1 POUCH (0280-1200-02)
0280-1200-0300280120003160 TABLET, FILM COATED in 1 BOTTLE (0280-1200-03)
0280-1200-04002801200041 BOTTLE in 1 CARTON (0280-1200-04) / 40 TABLET, FILM COATED in 1 BOTTLE
0280-1200-050028012000580 TABLET, FILM COATED in 1 BOTTLE (0280-1200-05)
0280-1200-08002801200081 BOTTLE in 1 CARTON (0280-1200-08) / 250 TABLET, FILM COATED in 1 BOTTLE
0280-1200-20002801200201 BOTTLE in 1 CARTON (0280-1200-20) / 20 TABLET, FILM COATED in 1 BOTTLE
0280-1200-40002801200401 BOTTLE in 1 CARTON (0280-1200-40) / 40 TABLET, FILM COATED in 1 BOTTLE
0280-1200-80002801200801 BOTTLE in 1 CARTON (0280-1200-80) / 80 TABLET, FILM COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0280-1200 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0280-1200 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0280-1200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.